Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Incyte’s Pemazyre for rare bile duct cancer

pharmatimesJuly 23, 2021

Tag: NICE , Incyte , Pemazyre , CCA

PharmaSources Customer Service